Lycopene inhibits urotensin-II-induced cardiomyocyte hypertrophy in neonatal rat cardiomyocytes

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Chao, Hung Hsing ^a,b   Sung, Li Chin ^c,d   Chen, Cheng Hsien ^b   Liu, Ju Chi ^b,d   Chen, Jin Jer ^c,e   Cheng, Tzu Hurng ^c,f  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LYCOPENE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UROTENSIN II;

ANIMAL CELL; ARTICLE; CARDIOMYOCYTE HYPERTROPHY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME METABOLISM; ENZYME PHOSPHORYLATION; HEART PROTECTION; HYPERTROPHY; NEWBORN; NONHUMAN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION;

EID: 84902121569     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/724670     Document Type: Article

References (33)

1. Swynghedauw B., Remodeling of the heart in chronic pressure overload. Basic Research in Cardiology 1991 86 99 105 2-s2.0-0025929695
2. Wang Y., Signal transduction in cardiac hypertrophy-dissecting compensatory versus pathological pathways utilizing a transgenic approach. Current Opinion in Pharmacology 2001 1 2 134 140 2-s2.0-0035321572 10.1016/S1471-4892(01)00029-7
3. Ames R. S., Sarau H. M., Chambers J. K., Willette R. N., Alyar N. V., Romanic A. M., Louden C. S., Foley J. J., Sauermelch C. F., Coatney R. W., Ao Z., Disa J., Holmes S. D., Stadel J. M., Martin J. D., Liu W.-S., Glover G. I., Wilson S., McNulty D. E., Ellis C. E., Elshourbagy N. A., Shabon U., Trill J. J., Hay D. W. P., Ohlstein E. H., Bergsma D. J., Douglas S. A., Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 1999 401 6750 282 286 2-s2.0-0033598937
4. Ross B., McKendy K., Giaid A., Role of urotensin II in health and disease. American Journal of Physiology, Regulatory Integrative and Comparative Physiology 2010 298 5 R1156 R1172 2-s2.0-77951707590 10.1152/ajpregu.00706.2009
5. Liu J.-C., Chen C.-H., Chen J.-J., Cheng T.-H., Urotensin II induces rat cardiomyocyte hypertrophy via the transient oxidization of Src homology 2-containing tyrosine phosphatase and transactivation of epidermal growth factor receptor. Molecular Pharmacology 2009 76 6 1186 1195 2-s2.0-73149119394 10.1124/mol.109.058297
6. Djordjevic T., BelAiba R. S., Bonello S., Pfeilschifter J., Hess J., Görlach A., Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 3 519 525 2-s2.0-14644433774 10.1161/01.ATV.0000154279. 98244.eb
7. Li J.-M., Gall N. P., Grieve D. J., Chen M., Shah A. M., Activation of NADPH oxidase during progression of cardiac hypertrophy to failure. Hypertension 2002 40 4 477 484 2-s2.0-0036791698 10.1161/01.HYP.0000032031.30374.32
8. Gruson D., Ginion A., Decroly N., Lause P., Vanoverschelde J. L., Ketelslegers J. M., Bertrand L., Thissen J. P., Urotensin II induction of adult cardiomyocytes hypertrophy involves the Akt/GSK-3 β signaling pathway. Peptides 2010 31 7 1326 1333 2-s2.0-77952546031 10.1016/j.peptides.2010.04.009
9. Kerkelä R., Woulfe K., Force T., Glycogen synthase kinase-3 β -actively inhibiting hypertrophy. Trends in Cardiovascular Medicine 2007 17 3 91 96 2-s2.0-34047160093 10.1016/j.tcm.2007.01.004
10. Oudit G. Y., Sun H., Kerfant B.-G., Crackower M. A., Penninger J. M., Backx P. H., The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. Journal of Molecular and Cellular Cardiology 2004 37 2 449 471 2-s2.0-3242698804 10.1016/j.yjmcc.2004.05.015
11. Leslie N. R., Bennett D., Lindsay Y. E., Stewart H., Gray A., Downes C. P., Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO Journal 2003 22 20 5501 5510 2-s2.0-0142137134 10.1093/emboj/cdg513
12. Blum A., Monir M., Wirsansky I., Ben-Arzi S., The beneficial effects of tomatoes. European Journal of Internal Medicine 2005 16 6 402 404 2-s2.0-26044476163 10.1016/j.ejim.2005.02.017
13. Mordente A., Guantario B., Meucci E., Silvestrini A., Lombardi E., Martorana G. E., Giardina B., Böhm V., Lycopene and cardiovascular diseases: an update. Current Medicinal Chemistry 2011 18 8 1146 1163 2-s2.0-79952811360 10.2174/092986711795029717
14. Fuentes E., Carle R., Astudillo L., Guzmán L., Gutiérrez M., Carrasco G., Palomo I., Antioxidant and antiplatelet activities in extracts from green and fully ripe tomato fruits (Solanum lycopersicum) and pomace from industrial tomato processing. Evidence-based Complementary and Alternative Medicine 2013 2013 9 2-s2.0-84874873012 10.1155/2013/867578 867578
15. Trejo-Solis C., Pedraza-Chaverri J., Torres-Ramos M., Multiple molecular and cellular mechanisms of action of lycopene in cancer inhibition. Evidence-Based Complementary and Alternative Medicine 2013 2013 17 705121 10.1155/2013/705121
16. Rissanen T., Voutilainen S., Nyyssönen K., Salonen J. T., Lycopene, atherosclerosis, and coronary heart disease. Experimental Biology and Medicine 2002 227 10 900 907 2-s2.0-0036847624
17. Cheng T.-H., Shih N.-L., Chen C.-H., Lin H., Liu J.-C., Chao H.-H., Liou J.-Y., Chen Y.-L., Tsai H.-W., Chen Y.-S., Cheng C.-F., Chen J.-J., Role of mitogen-activated protein kinase pathway in reactive oxygen species-mediated endothelin-1-induced β -myosin heavy chain gene expression and cardiomyocyte hypertrophy. Journal of Biomedical Science 2005 12 1 123 133 2-s2.0-20944437464 10.1007/s11373-004-8168-6
18. Hsu Y.-H., Chen Y.-C., Chen T.-H., Sue Y.-M., Cheng T.-H., Chen J.-R., Chen C.-H., Far-infrared therapy induces the nuclear translocation of PLZF which inhibits VEGF-induced proliferation in human umbilical vein endothelial cells. PLoS ONE 2012 7 1 2-s2.0-84856103745 10.1371/journal.pone.0030674 e30674
19. Hardt S. E., Sadoshima J., Glycogen synthase kinase-3 β a novel regulator of cardiac hypertrophy and development. Circulation Research 2002 90 10 1055 1063 2-s2.0-0037205315 10.1161/01.RES.0000018952.70505.F1
20. Kitagishi Y., Matsuda S., Redox regulation of tumor suppressor PTEN in cancer and aging (Review). International Journal of Molecular Medicine 2013 31 3 511 515 2-s2.0-84873148285 10.3892/ijmm.2013.1235
21. Gebremedhin D., Terashvili M., Wickramasekera N., Redox signaling via oxidative inactivation of PTEN modulates pressure-dependent myogenic tone in rat middle cerebral arteries. PLoS ONE 2013 8 7 e68498 10.1371/journal.pone.0068498
22. Oudit G. Y., Penninger J. M., Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovascular Research 2009 82 2 250 260 2-s2.0-62349105876 10.1093/cvr/cvp014
23. Mohamadin A. M., Elberry A. A., Mariee A. D., Morsy G. M., Al-Abbasi F. A., Lycopene attenuates oxidative stress and heart lysosomal damage in isoproterenol induced cardiotoxicity in rats: a biochemical study. Pathophysiology 2012 19 2 121 130 2-s2.0-84861922068 10.1016/j.pathophys.2012. 04.005
24. Bohm V., Lycopene and heart health. Molecular Nutrition & Food Research 2012 56 2 296 303 10.1002/mnfr.201100281
25. 2-induced cell death in H9c2. Food Chemistry 2013 136 2 878 888 2-s2.0-84866872496 10.1016/j.foodchem.2012.08.020
26. Palozza P., Parrone N., Simone R., Catalano A., Role of lycopene in the control of ROS-mediated cell growth: implications in cancer prevention. Current Medicinal Chemistry 2011 18 12 1846 1860 2-s2.0-79955702718 10.2174/ 092986711795496845
27. Simone R. E., Russo M., Catalano A., Monego G., Froehlich K., Boehm V., Palozza P., Lycopene inhibits NF-KB-Mediated IL-8 expression and changes redox and PPAR γ signalling in cigarette smoke-stimulated macrophages. PLoS ONE 2011 6 5 2-s2.0-79956282901 10.1371/journal.pone.0019652 e19652
28. Palozza P., Simone R., Catalano A., Boninsegna A., Böhm V., Fröhlich K., Mele M. C., Monego G., Ranelletti F. O., Lycopene prevents 7-ketocholesterol-induced oxidative stress, cell cycle arrest and apoptosis in human macrophages. Journal of Nutritional Biochemistry 2010 21 1 34 46 2-s2.0-71749099655 10.1016/j.jnutbio.2008.10.002
29. Sugden P. H., Clerk A., Oxidative stress and growth-regulating intracellular signaling pathways in cardiac myocytes. Antioxidants and Redox Signaling 2006 8 11-12 2111 2124 2-s2.0-33947689707
30. Rice K. M., Uddemarri S., Desai D. H., Morrison R. G., Harris R., Wright G. L., Blough E. R., PGF2 α -associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN. Prostaglandins and Other Lipid Mediators 2008 85 1-2 49 57 2-s2.0-38049038824 10.1016/j.prostaglandins.2007.10.009
31. Planavila A., Rodríguez-Calvo R., Palomer X., Coll T., Sánchez R. M., Merlos M., Laguna J. C., Vázquez-Carrera M., Atorvastatin inhibits GSK-3 β phosphorylation by cardiac hypertrophic stimuli. Biochimica et Biophysica Acta, Molecular and Cell Biology of Lipids 2008 1781 1-2 26 35 2-s2.0-39149096851 10.1016/j.bbalip.2007.10.009
32. Crackower M. A., Oudit G. Y., Kozieradzki I., Sarao R., Sun H., Sasaki T., Hirsch E., Suzuki A., Shioi T., Irie-Sasaki J., Sah R., Cheng H.-Y. M., Rybin V. O., Lembo G., Fratta L., Oliveira-dos-Santos A. J., Benovic J. L., Kahn C. R., Izumo S., Steinberg S. F., Wymann M. P., Backx P. H., Penninger J. M., Regulation of myocardial contractility and cell size by distinct PI3K-PTEN signaling pathways. Cell 2002 110 6 737 749 2-s2.0-18644372367 10.1016/S0092-8674(02)00969-8
33. Schwartzbauer G., Robbins J., The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival. The Journal of Biological Chemistry 2001 276 38 35786 35793 2-s2.0-0035929596 10.1074/jbc.M102479200